Tamoxifen added to adjuvant chemotherapy in premenopausal women with early breast cancer: is it standard practice or still a subject for study?
Academic Article
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- November 1999
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Aged (MeSH)
- Antineoplastic Agents, Hormonal (MeSH)
- Breast Neoplasms (MeSH)
- Chemotherapy, Adjuvant (MeSH)
- Clinical Trials as Topic (MeSH)
- Female (MeSH)
- Humans (MeSH)
- Middle Aged (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Premenopause (MeSH)
- Professional Practice (MeSH)
- Tamoxifen (MeSH)
published in
- European Journal of Cancer Journal